View Future GrowthSeri Industrial 過去の業績過去 基準チェック /16Seri Industrialは、平均年間54%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 減少しています。収益は、平均年間7.7% 13.4%収益成長率で 成長しています。 Seri Industrialの自己資本利益率は9.4%であり、純利益率は5.5%です。主要情報53.96%収益成長率54.21%EPS成長率Chemicals 業界の成長12.41%収益成長率13.43%株主資本利益率9.36%ネット・マージン5.50%前回の決算情報31 Dec 2025最近の業績更新Reported Earnings • Oct 02First half 2024 earnings releasedFirst half 2024 results: Revenue: €94.2m (up 4.9% from 1H 2023). Net loss: €5.72m (loss narrowed 18% from 1H 2023). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany.Reported Earnings • Apr 03Full year 2023 earnings releasedFull year 2023 results: Revenue: €200.1m (up 7.2% from FY 2022). Net loss: €11.2m (loss widened 156% from FY 2022). Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany.Reported Earnings • Sep 25First half 2023 earnings releasedFirst half 2023 results: Revenue: €89.8m (down 4.2% from 1H 2022). Net loss: €7.04m (loss widened 37% from 1H 2022). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 8.7% growth forecast for the Electrical industry in Germany.すべての更新を表示Recent updatesValuation Update With 7 Day Price Move • Jul 13Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.29, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 15x in the Chemicals industry in Germany. Total loss to shareholders of 27% over the past three years.New Risk • Jul 09New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 6.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings are forecast to decline by an average of 6.9% per year for the foreseeable future. High level of non-cash earnings (44% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (5.5% net profit margin).Valuation Update With 7 Day Price Move • May 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.58, the stock trades at a trailing P/E ratio of 10.3x. Average forward P/E is 17x in the Chemicals industry in Germany. Total loss to shareholders of 30% over the past three years.Board Change • May 20Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 9 experienced directors. 2 highly experienced directors. 4 independent directors (6 non-independent directors). Independent Director & Advisor Antonio Guglielmi was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 02First half 2024 earnings releasedFirst half 2024 results: Revenue: €94.2m (up 4.9% from 1H 2023). Net loss: €5.72m (loss narrowed 18% from 1H 2023). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany.New Risk • Apr 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Apr 03Full year 2023 earnings releasedFull year 2023 results: Revenue: €200.1m (up 7.2% from FY 2022). Net loss: €11.2m (loss widened 156% from FY 2022). Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany.New Risk • Oct 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€19m free cash flow). Share price has been highly volatile over the past 3 months (8.5% average weekly change). Minor Risk Shareholders have been diluted in the past year (9.3% increase in shares outstanding).Reported Earnings • Sep 25First half 2023 earnings releasedFirst half 2023 results: Revenue: €89.8m (down 4.2% from 1H 2022). Net loss: €7.04m (loss widened 37% from 1H 2022). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 8.7% growth forecast for the Electrical industry in Germany.Board Change • Sep 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Chairman of the Board Roberto Maviglia was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.収支内訳Seri Industrial の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:PCHP 収益、費用、利益 ( )EUR Millions日付収益収益G+A経費研究開発費31 Dec 253001768030 Sep 252841967030 Jun 252682267031 Mar 252452458031 Dec 242222650030 Sep 24203842030 Jun 24183-1034031 Mar 24184-1033031 Dec 23185-1132030 Jun 23176-430031 Mar 23179-430031 Dec 22182-330030 Sep 22183-331030 Jun 22180-231031 Mar 22173-231031 Dec 21165-230030 Sep 21159-130030 Jun 21153-130031 Mar 21142-328031 Dec 20130-427030 Jun 20131-427031 Mar 20140-128031 Dec 19149228030 Jun 19133023031 Mar 19127322031 Dec 18121521030 Sep 18125622030 Jun 18128623031 Mar 1897317031 Dec 1767012030 Sep 1730-47030 Jun 172-61031 Mar 171-61031 Dec 161-51030 Sep 169-41030 Jun 165-41031 Mar 163-41031 Dec 156-51030 Sep 153-310質の高い収益: PCHP 非現金収入 のレベルが高いです。利益率の向上: PCHPの現在の純利益率 (5.5%)は、昨年(11.8%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: PCHP過去 5 年間で収益を上げており、収益は年間54%増加しています。成長の加速: PCHPは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: PCHPは過去 1 年間で収益成長率がマイナス ( -36.9% ) となったため、 Chemicals業界平均 ( 3.3% ) と比較することが困難です。株主資本利益率高いROE: PCHPの 自己資本利益率 ( 9.4% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/06 17:30終値2026/08/06 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Seri Industrial S.p.A. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。6 アナリスト機関Luca BacoccoliIntesa Sanpaolo Equity ResearchAlberto FranceseIntesa Sanpaolo Equity ResearchMonica BosioIntesa Sanpaolo Equity Research3 その他のアナリストを表示
Reported Earnings • Oct 02First half 2024 earnings releasedFirst half 2024 results: Revenue: €94.2m (up 4.9% from 1H 2023). Net loss: €5.72m (loss narrowed 18% from 1H 2023). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Apr 03Full year 2023 earnings releasedFull year 2023 results: Revenue: €200.1m (up 7.2% from FY 2022). Net loss: €11.2m (loss widened 156% from FY 2022). Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany.
Reported Earnings • Sep 25First half 2023 earnings releasedFirst half 2023 results: Revenue: €89.8m (down 4.2% from 1H 2022). Net loss: €7.04m (loss widened 37% from 1H 2022). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 8.7% growth forecast for the Electrical industry in Germany.
Valuation Update With 7 Day Price Move • Jul 13Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.29, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 15x in the Chemicals industry in Germany. Total loss to shareholders of 27% over the past three years.
New Risk • Jul 09New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 6.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Share price has been highly volatile over the past 3 months (19% average weekly change). Earnings are forecast to decline by an average of 6.9% per year for the foreseeable future. High level of non-cash earnings (44% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (5.5% net profit margin).
Valuation Update With 7 Day Price Move • May 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.58, the stock trades at a trailing P/E ratio of 10.3x. Average forward P/E is 17x in the Chemicals industry in Germany. Total loss to shareholders of 30% over the past three years.
Board Change • May 20Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 9 experienced directors. 2 highly experienced directors. 4 independent directors (6 non-independent directors). Independent Director & Advisor Antonio Guglielmi was the last independent director to join the board, commencing their role in 2025. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 02First half 2024 earnings releasedFirst half 2024 results: Revenue: €94.2m (up 4.9% from 1H 2023). Net loss: €5.72m (loss narrowed 18% from 1H 2023). Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Germany.
New Risk • Apr 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Apr 03Full year 2023 earnings releasedFull year 2023 results: Revenue: €200.1m (up 7.2% from FY 2022). Net loss: €11.2m (loss widened 156% from FY 2022). Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 3.8% growth forecast for the Chemicals industry in Germany.
New Risk • Oct 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 8.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-€19m free cash flow). Share price has been highly volatile over the past 3 months (8.5% average weekly change). Minor Risk Shareholders have been diluted in the past year (9.3% increase in shares outstanding).
Reported Earnings • Sep 25First half 2023 earnings releasedFirst half 2023 results: Revenue: €89.8m (down 4.2% from 1H 2022). Net loss: €7.04m (loss widened 37% from 1H 2022). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 8.7% growth forecast for the Electrical industry in Germany.
Board Change • Sep 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Chairman of the Board Roberto Maviglia was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.